Publications To Date


    Filter Publications

    PAGE 3 OF 78 | DISPLAYING 31 - 45 OF 1166 RESULTS

    Warchal SJ et al., High content phenotypic screening identifies serotonin receptor modulators with selective activity upon breast cancer cell cycle and cytokine signaling pathways, , Bioorg Med Chem., Nov 09, 2019

    Lee JS et al., Phase I clinical trial of the combination of eribulin and everolimus in patients with metastatic triple-negative breast cancer., , Breast Cancer Res, Nov 08, 2019

    Ihle CL et al., Distinct tumor microenvironments of lytic and blastic bone metastases in prostate cancer patients., , J Immunother Cancer, Nov 08, 2019

    Mhawech-Fauceglia P et al., Genomic heterogeneity in peritoneal implants: A differential analysis of gene expression using nanostring Human Cancer Reference panel identifies a malignant signature., , Gynecol Oncol, Nov 08, 2019

    Abdulla M et al., Cell‐of‐origin determined by both gene expression profiling and immunohistochemistry is the strongest predictor of survival in patients with diffuse large B‐cell lymphoma, , Am J Hematol., Nov 07, 2019

    Mahalingam D et al., Pembrolizumab in combination with the oncolytic virus pelareorep and chemotherapy in patients with advanced pancreatic adenocarcinoma: a Phase 1b study, , Clin Cancer Res, Nov 06, 2019

    Yan W et al., Molecular profiling of radical prostatectomy tissue from patients with no sign of progression identifies ERG as the strongest independent predictor of recurrence., , Oncotarget, Nov 05, 2019

    Taibi A et al., Effects of Flaxseed and Its Components on Mammary Gland MiRNome: Identification of Potential Biomarkers to Prevent Breast Cancer Development, , Nutrients, Nov 04, 2019

    Damotte D et al., The tumor inflammation signature (TIS) is associated with anti-PD-1 treatment benefit in the CERTIM pan-cancer cohort., , J Transl Med., Nov 04, 2019

    Yu J et al., Genetic Aberrations in the CDK4 Pathway Are Associated with Innate Resistance to PD-1 Blockade in Chinese Patients with Non-Cutaneous Melanoma., , Clin Cancer Res, Nov 01, 2019

    Mog B et al., Nano-Antagonist Alleviates Inflammation and Allows for MRI of Atherosclerosis., , Nanotheranostics, Nov 01, 2019

    Yarchoan M et al., MEK inhibition suppresses B regulatory cells and augments anti-tumor immunity., , PLoS One, Oct 31, 2019

    Fattore L et al., Single cell analysis to dissect molecular heterogeneity and disease evolution in metastatic melanoma., , Cell Death Dis, Oct 31, 2019

    Canon J et al., The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity , , Nature, Oct 30, 2019

    Giannini R et al., Immune Profiling of Thyroid Carcinomas Suggests the Existence of Two Major Phenotypes: An ATC-Like and a PDTC-Like., , J Clin Endocrinol Metab, Oct 28, 2019